Skip to main content
Overview
Investor Relations
Overview
Why Invest
News & Events
News
Events & Presentations
Pfizer Pflash
Financials
Quarterly Results
Annual Reports
SEC Filings
Stock & Dividend
Stock Information
Dividend & Split History
Corporate Governance
Corporate Governance Overview
Impact Reports
Board of Directors
Board Committees & Charters
Board Policies
Corporate Governance FAQs
Contact Our Directors
Shareholder Services
Shareholder Services Overview
Investor FAQs
Prospective Investors
Cost Basis Calculator
Investor Email Alerts
Science
Clinical Trials
Guide to Clinical Trials
Clinical Trials in Children
Data and Results
Integrity and Transparency
Diversity
Plain Language Study Results
Expanded Access & Compassionate Use
Find a Trial
Areas of Focus
Internal Medicine
Inflammation & Immunology
Vaccines
Oncology
Diseases & Conditions
Product Pipeline
Research Sites
Products
How Drugs Are Made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Global Supply
Manufacturing Sites
Medicine Safety
Health Literacy
Treatment Choices
Partnering with Patients
Tips for Patients
Reporting Adverse Events
Counterfeiting
Product Safety
Product List
Product Contacts
PfizerForAll
PfizerPro for Professionals
Patient Assistance Programs
Distributors
Pfizer Distributors
Stories
Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Newsroom
Press Releases
Media Asset Library
Update & Statements
Partnering News
Media Contacts
About
Leadership
Purpose & History
Responsibility
Responsible Business
Global Impact
Diversity, Equity, and Inclusion
Environmental Sustainability
Health & Safety
Global HCP/HCO/PO Transparency Reporting
Misinformation
Antimicrobial Resistance
Principles & Policies
Ethics & Compliance
Political Partnership
Prescription Value & Pricing
Policy Positions
Ready for Cures
Partnering with Others
Funding Global Health Through Grants
Patient Advocacy & Engagement
Working with Healthcare Professionals
Research and Business Development Partnerships
Venture Investments
Supplier & Business-to-Business Resources
Pfizer CentreOne
Skip to main content
Overview
Investor Relations
Overview
Why Invest
News & Events
News
Events & Presentations
Pfizer Pflash
Financials
Quarterly Results
Annual Reports
SEC Filings
Stock & Dividend
Stock Information
Dividend & Split History
Corporate Governance
Corporate Governance Overview
Impact Reports
Board of Directors
Board Committees & Charters
Board Policies
Corporate Governance FAQs
Contact Our Directors
Shareholder Services
Shareholder Services Overview
Investor FAQs
Prospective Investors
Cost Basis Calculator
Investor Email Alerts
Science
Clinical Trials
Guide to Clinical Trials
Clinical Trials in Children
Data and Results
Integrity and Transparency
Diversity
Plain Language Study Results
Expanded Access & Compassionate Use
Find a Trial
Areas of Focus
Internal Medicine
Inflammation & Immunology
Vaccines
Oncology
Diseases & Conditions
Product Pipeline
Research Sites
Products
How Drugs Are Made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Global Supply
Manufacturing Sites
Medicine Safety
Health Literacy
Treatment Choices
Partnering with Patients
Tips for Patients
Reporting Adverse Events
Counterfeiting
Product Safety
Product List
Product Contacts
PfizerForAll
PfizerPro for Professionals
Patient Assistance Programs
Distributors
Pfizer Distributors
Stories
Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Newsroom
Press Releases
Media Asset Library
Update & Statements
Partnering News
Media Contacts
About
Leadership
Purpose & History
Responsibility
Responsible Business
Global Impact
Diversity, Equity, and Inclusion
Environmental Sustainability
Health & Safety
Global HCP/HCO/PO Transparency Reporting
Misinformation
Antimicrobial Resistance
Principles & Policies
Ethics & Compliance
Political Partnership
Prescription Value & Pricing
Policy Positions
Ready for Cures
Partnering with Others
Funding Global Health Through Grants
Patient Advocacy & Engagement
Working with Healthcare Professionals
Research and Business Development Partnerships
Venture Investments
Supplier & Business-to-Business Resources
Pfizer CentreOne
Current Location and Language
United States
-
English
Argentina
-
Español
Australia
-
English
Austria
-
Deutsch
Belarus
-
Belarusian
-
English
Belgium
-
English
-
Nederlands
-
Français
Brazil
-
Português
Bulgaria
-
Български
Canada
-
English
-
Français
China
-
中文
-
English
Chile
-
Español
Colombia
-
Español
Croatia
-
Croatian
Czech Republic
-
Čeština
Denmark
-
Dansk
Ecuador
-
Español
Estonia
-
Eesti
-
English
Finland
-
Suomalainen
France
-
Français
Germany
-
Deutsch
Greece
-
ελληνικά
Hong Kong
-
繁體中文
-
English
Hungary
-
Magyar
India
-
English
Indonesia
-
Indonesian
Ireland
-
English
Israel
-
עברית
Italy
-
Italiano
Japan
-
日本の
Korea
-
한국의
Latvia
-
Latvian
-
English
Lithuania
-
Lithuanian
-
English
Malaysia
-
English
Mexico
-
Español
Netherlands
-
Nederlands
New Zealand
-
English
Norway
-
Norsk
Pakistan
-
English
Peru
-
Español
Philippines
-
English
Poland
-
Polski
Portugal
-
Português
Russia
-
Русский
Romania
-
Română
Serbia
-
Serbian
Saudi Arabia
-
English
-
العربية
Singapore
-
English
Slovenia
-
Slovenian
Slovakia
-
Slovenský
South Africa
-
English
Spain
-
Español
Sweden
-
Svenska
Switzerland
-
Deutsch
-
Français
Taiwan
-
Taiwan
Thailand
-
ภาษาไทย
Tunisia
-
Français
Turkey
-
Türk
United Kingdom
-
English
United States
-
English
Ukraine
-
Ukrainian
Vietnam
-
Tiếng Việt
-
English
Venezuela
-
Español
Event Details
Overview
>
Investor Relations
>
News & Events
>
Event Details
LEERINK PARTNERS ROUNDTABLE SERIES: RARE DISEASE AND IMMUNO-ONCOLOGY
09/28/2017 9:00 AM ET
Transcript
(opens in new window)